Literature DB >> 30663680

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart.

Santosh K Yadav1, Paras K Mishra2.   

Abstract

Myocardial infarction (MI) is a leading cause of morbidity and mortality around the world. A major goal of regenerative medicine is to replenish the dead myocardium after MI. Although several strategies have been used to regenerate myocardium, stem cell therapy remains a major approach to replenish the dead myocardium of an MI heart. Accumulating evidence suggests the presence of resident cardiac stem cells (CSCs) in the adult heart and their endocrine and/or paracrine effects on cardiac regeneration. However, CSC isolation and their characterization and differentiation toward myocardial cells, especially cardiomyocytes, remains a technical challenge. In the present study, we provided a simple method for the isolation, characterization, and differentiation of CSCs from the adult mouse heart. Here, we describe a density gradient method for the isolation of CSCs, where the heart is digested by a 0.2% collagenase II solution. To characterize the isolated CSCs, we evaluated the expression of CSCs/cardiac markers Sca-1, NKX2-5, and GATA4, and pluripotency/stemness markers OCT4, SOX2, and Nanog. We also determined the proliferation potential of isolated CSCs by culturing them in a Petri dish and assessing the expression of the proliferation marker Ki-67. For evaluating the differentiation potential of CSCs, we selected seven- to ten-days cultured CSCs. We transferred them to a new plate with a cardiomyocyte differentiation medium. They are incubated in a cell culture incubator for 12 days, while the differentiation medium is changed every three days. The differentiated CSCs express cardiomyocyte-specific markers: actinin and troponin I. Thus, CSCs isolated with this protocol have stemness and cardiac markers, and they have a potential for proliferation and differentiation toward cardiomyocyte lineage.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30663680      PMCID: PMC7207148          DOI: 10.3791/58448

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  36 in total

1.  Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts.

Authors:  Marc-Michael Zaruba; Mark Soonpaa; Sean Reuter; Loren J Field
Journal:  Circulation       Date:  2010-04-26       Impact factor: 29.690

Review 2.  Exosomes and cardiac repair after myocardial infarction.

Authors:  Susmita Sahoo; Douglas W Losordo
Journal:  Circ Res       Date:  2014-01-17       Impact factor: 17.367

3.  Embryonic stem cell therapy of heart failure in genetic cardiomyopathy.

Authors:  Satsuki Yamada; Timothy J Nelson; Ruben J Crespo-Diaz; Carmen Perez-Terzic; Xiao-Ke Liu; Takashi Miki; Susumu Seino; Atta Behfar; Andre Terzic
Journal:  Stem Cells       Date:  2008-07-31       Impact factor: 6.277

4.  Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.

Authors:  Bojan Vrtovec; Gregor Poglajen; Luka Lezaic; Matjaz Sever; Dragoslav Domanovic; Peter Cernelc; Aljaz Socan; Sonja Schrepfer; Guillermo Torre-Amione; François Haddad; Joseph C Wu
Journal:  Circ Res       Date:  2012-10-12       Impact factor: 17.367

5.  A strong regenerative ability of cardiac stem cells derived from neonatal hearts.

Authors:  David L Simpson; Rachana Mishra; Sudhish Sharma; Saik Kia Goh; Savitha Deshmukh; Sunjay Kaushal
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

6.  Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology.

Authors:  Anke M Smits; Patrick van Vliet; Corina H Metz; Tom Korfage; Joost Pg Sluijter; Pieter A Doevendans; Marie-José Goumans
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

7.  Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial.

Authors:  Lian R Gao; Yu Chen; Ning K Zhang; Xi L Yang; Hui L Liu; Zhi G Wang; Xiao Y Yan; Yu Wang; Zhi M Zhu; Tian C Li; Li H Wang; Hai Y Chen; Yun D Chen; Chao L Huang; Peng Qu; Chen Yao; Bin Wang; Guang H Chen; Zhong M Wang; Zhao Y Xu; Jing Bai; Di Lu; Yan H Shen; Feng Guo; Mu Y Liu; Yong Yang; Yan C Ding; Ye Yang; Hai T Tian; Qing A Ding; Li N Li; Xin C Yang; Xiang Hu
Journal:  BMC Med       Date:  2015-07-10       Impact factor: 8.775

8.  Exosomes as critical agents of cardiac regeneration triggered by cell therapy.

Authors:  Ahmed Gamal-Eldin Ibrahim; Ke Cheng; Eduardo Marbán
Journal:  Stem Cell Reports       Date:  2014-05-08       Impact factor: 7.765

9.  Isolation and characterization of a Sca-1+/CD31- progenitor cell lineage derived from mouse heart tissue.

Authors:  Hao Wang; Hao Chen; Bei Feng; Xiang Wang; Xiaomin He; Renjie Hu; Meng Yin; Wei Wang; Wei Fu; Zhiwei Xu
Journal:  BMC Biotechnol       Date:  2014-08-09       Impact factor: 2.563

10.  Pretreatment of Cardiac Stem Cells With Exosomes Derived From Mesenchymal Stem Cells Enhances Myocardial Repair.

Authors:  Zhiwei Zhang; Junjie Yang; Weiya Yan; Yangxin Li; Zhenya Shen; Takayuki Asahara
Journal:  J Am Heart Assoc       Date:  2016-01-25       Impact factor: 5.501

View more
  1 in total

1.  Feline hypertrophic cardiomyopathy: reduced microvascular density and involvement of CD34+ interstitial cells.

Authors:  Josep M Monné Rodríguez; Sonja Fonfara; Udo Hetzel; Anja Kipar
Journal:  Vet Pathol       Date:  2021-12-27       Impact factor: 2.221

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.